Contact dermatitis due to topical drugs

Area of Science:

• Dermatology
• Allergology
• Pharmacology

Background:

• Contact dermatitis from topical drugs is a significant clinical challenge.
• Patients with chronic leg ulcers are particularly susceptible to topical drug and antiseptic-induced dermatitis.
• Identifying the causative agent, whether the drug or its excipient, is essential for effective management.

Purpose of the Study:

• To outline diagnostic and management strategies for contact dermatitis caused by topical medications.
• To emphasize the importance of dermatoallergological investigations in identifying specific allergens.
• To provide guidance on cross-reactivity and contraindications for drug re-administration.

Main Methods:

• Review of diagnostic approaches including drug patch tests and diluted prick tests.
• Analysis of potential cross-reactivity among different drug classes, including NSAIDs and corticosteroids.
• Identification of specific contraindications for photosensitizing agents and corticosteroids.

Main Results:

• Dermatoallergological investigations are key to distinguishing between drug and excipient sensitization.
• Excipients causing sensitization can be found in cosmetics, necessitating INCI name identification.
• Specific cross-reactivity patterns exist within NSAIDs, and photosensitization contraindications are identified for certain drugs.
• Corticosteroid sensitization requires class-specific avoidance.

Conclusions:

• Effective management of topical drug contact dermatitis requires accurate diagnosis through allergy testing.
• Patient counseling on avoiding both topical and systemic re-exposure to the offending agent is paramount.
• Understanding cross-reactivity and contraindications is vital for preventing adverse drug reactions.